12-15-2021, 08:18 AM
PFIZER’S NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE REDUCED RISK OF HOSPITALIZATION OR DEATH BY 89% IN INTERIM ANALYSIS OF PHASE 2/3 EPIC-HR STUDY
https://www.pfizer.com/news/press-releas...-candidate
https://www.pfizer.com/news/press-releas...dy-results
https://www.cbsnews.com/news/pfizer-covi...-efficacy/
https://www.pfizer.com/news/press-releas...-candidate
https://www.pfizer.com/news/press-releas...dy-results
https://www.cbsnews.com/news/pfizer-covi...-efficacy/